Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non–Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Cl...

Por Sun, Alexander, Hu, Chen, Wong, Stuart J., Gore, Elizabeth, Videtic, Gregory, Dutta, Swati, Suntharalingam, Mohan, Chen, Yuhchyau, Gaspar, Laurie E., Choy, Hak
Publicado no JAMA Oncol (2019)

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Onco...

Por Gore, Elizabeth M., Bae, Kyounghwa, Wong, Stuart J., Sun, Alexander, Bonner, James A., Schild, Steven E., Gaspar, Laurie E., Bogart, Jeffery A., Werner-Wasik, Maria, Choy, Hak
Publicado em 2011

De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies

Por Mehanna, Hisham, Rischin, Danny, Wong, Stuart J., Gregoire, Vincent, Ferris, Robert, Waldron, John, Le, Quynh-Thu, Forster, Martin, Gillison, Maura, Laskar, Sarbani, Tahara, Makoto, Psyrri, Amanda, Vermorken, Jan, Porceddu, Sandro
Publicado no J Clin Oncol (2020)

Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analy...

Por Sun, Alexander, Bae, Kyounghwa, Gore, Elizabeth M., Movsas, Benjamin, Wong, Stuart J., Meyers, Christina A., Bonner, James A., Schild, Steven E., Gaspar, Laurie E., Bogart, Jeffery A., Werner-Wasik, Maria, Choy, Hak
Publicado em 2011

RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Patients with Locally Advanc...

Por Wong, Stuart J., Winter, Kathryn, Meropol, Neal J., Anne, Pramila Rani, Kachnic, Lisa, Rashid, Asif, Watson, James C., Mitchell, Edith, Pollock, Jondavid, Lee, R. Jeffrey, Haddock, Michael, Erickson, Beth A., Willett, Christopher G.
Publicado em 2011

Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patien...

Por Wong, Stuart J., Moughan, J., Meropol, Neal J., Anne, Pramila Rani, Kachnic, Lisa A., Rashid, Asif, Watson, James C., Mitchell, Edith P., Pollock, Jondavid, Lee, R. Jeffrey, Haddock, Michael, Erickson, Beth A., Willett, Christopher G.
Publicado no Int J Radiat Oncol Biol Phys (2014)

A Phase I Trial of Aminolevulinic Acid-Photodynamic Therapy for Treatment of Oral Leukoplakia

Por Wong, Stuart J., Campbell, Bruce, Massey, Becky, Lynch, Denis P., Cohen, Ezra E. W., Blair, Elizabeth, Selle, Rebecca, Shklovskaya, Julia, Jovanovic, Borko D., Skripkauskas, Silvia, Dew, Alexander, Kulesza, Peter, Parimi, Vamsi, Bergan, Raymond C., Szabo, Eva
Publicado no Oral Oncol (2013)

E3611- A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High Dose Interferon-α2b in Advanced Melanoma

Por Tarhini, Ahmad A., Lee, Sandra J., Li, Xiaoxue, Rao, Uma N. M., Nagarajan, Arun, Albertini, Mark R., Mitchell, Jerry W., Wong, Stuart J., Taylor, Mark A., Laudi, Noel, Truong, Phu V., Conry, Robert M., Kirkwood, John M.
Publicado no Clin Cancer Res (2018)

A Phase II Study of Erlotinib and Bevacizumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Por Cohen, Ezra EW, Davis, Darren W., Karrison, Theodore G, Seiwert, Tanguy Y., Wong, Stuart J., Nattam, Sreenivasa, Kozloff, Mark F., Clark, Joseph I., Yan, Duen-Hwa, Liu, Wen, Pierce, Carolyn, Dancey, Janet E, Stenson, Kerstin, Blair, Elizabeth, Dekker, Allison, Vokes, Everett E
Publicado em 2009

A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Por de Souza, Jonas A., Davis, Darren W., Zhang, Yujian, Khattri, Arun, Seiwert, Tanguy Y., Aktolga, Serdal, Wong, Stuart J., Kozloff, Mark F., Nattam, Sreenivasa, Lingen, Mark W., Kunnavakkam, Rangesh, Stenson, Kerstin, Blair, Elizabeth A., Bozeman, Jeffrey, Dancey, Janet E., Vokes, Everett E., Cohen, Ezra E. W.
Publicado no Clin Cancer Res (2012)

Validation of NRG Oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer (OPC); implications for risk-based therapeutic intensity trial...

Por Fakhry, Carole, Zhang, Qiang, Gillison, Maura L, Nguyen-Tân, Phuc Felix, Rosenthal, David I, Weber, Randal S, Lambert, Louise, Trotti, Andy M, Barrett, William L, Thorstad, Wade L, Yom, Sue S, Wong, Stuart J, Ridge, John A, Rao, Shyam S D, Spencer, Sharon, Fortin, Andre, Raben, David, Harris, Jonathan, Le, Quynh-Thu
Publicado no Cancer (2019)

Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer

Por Mell, Loren K., Shen, Hanjie, Nguyen-Tân, Phuc Felix, Rosenthal, David I., Zakeri, Kaveh, Vitzthum, Lucas K., Frank, Steven J., Schiff, Peter B., Trotti, Andrea M., Bonner, James A., Jones, Christopher U., Yom, Sue S., Thorstad, Wade L., Wong, Stuart J., Shenouda, George, Ridge, John A., Zhang, Qiang E., Le, Quynh-Tu
Publicado no Clin Cancer Res (2019)

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer

Por Fakhry, Carole, Zhang, Qiang, Nguyen-Tân, Phuc Felix, Rosenthal, David I., Weber, Randal S., Lambert, Louise, Trotti, Andy M., Barrett, William L., Thorstad, Wade L., Jones, Christopher U., Yom, Sue S., Wong, Stuart J., Ridge, John A., Rao, Shyam S.D., Bonner, James A., Vigneault, Eric, Raben, David, Kudrimoti, Mahesh R., Harris, Jonathan, Le, Quynh-Thu, Gillison, Maura L.
Publicado no J Clin Oncol (2017)